Skip to main content
Clinical Trials/CTRI/2021/03/031926
CTRI/2021/03/031926
Not Yet Recruiting
N/A

Validation of artificial intelligence (AI) based pathology solution in scoring of biomarker expression in breast cancer and its impact on clinical decision making in breast cancer therapy

Applied Materials India PVT LTD0 sites0 target enrollmentTBD

Overview

Phase
N/A
Intervention
Not specified
Conditions
Health Condition 1: C509- Malignant neoplasm of breast of unspecified site
Sponsor
Applied Materials India PVT LTD
Status
Not Yet Recruiting
Last Updated
4 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
4 years ago
Study Type
Observational

Investigators

Sponsor
Applied Materials India PVT LTD

Eligibility Criteria

Inclusion Criteria

  • Female patients, post\-surgery with diagnosed breast carcinoma subjected to immunohistochemical analysis of hormone receptors(ER, PR, Her2\-neu and Ki67\) on the breast specimen.

Exclusion Criteria

  • Cases were consent could not be obtained

Outcomes

Primary Outcomes

Not specified

Similar Trials